Influenza flu, the U.S made vaccines.
United States Influenza Vaccines market is set to touch US$ 3.5 Billion threshold by 2025. Presents an in-depth assessment of the United States influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. Offers the most up-to-date industry data on the actual market situation and future outlook for United States influenza vaccines market and includes historic data from 2013 to 2017 and forecasts until 2025. Key market players Novavax Daiichi–Sankyo Mitsubishi TanabePharma and Biondvax Pharmaceuticals Ltd Major companies dominating this market Seqirus, Sanofi Pasteur, GlaxoSmithKline (GSK) and AstraZeneca The Latest Industry Data Included • United States Influenza Vaccines Market Size & Analysis (2013 - 2025) • United States Number of Persons Vaccinated • United States Number of Children Vaccinated • United States Number of Adults Vaccinated • United States Influenza Vaccines Pricing Trend...